Padideh Kamali-Zare - KTH Innovation Award 2023
At 14 she took care of her grandmother, who was diagnosed with mild dementia. Today, Padideh Kamali-Zare is the CEO and founder of biotech company Darmiyan, developing groundbreaking medical technology to help patients with neurodegenerative diseases like Alzheimer’s access better health and care.
Meet Padideh Kamali-Zare
The 2023 KTH Innovation Award goes to Padideh Kamali-Zare. She is head of the innovative Silicon Valley-based biotech company Darmiyan , and she has been able to realise her vision of helping patients with neurodegenerative diseases like Alzheimer’s to access better health and care.
“Darmiyan is focused on developing medical technology that can detect Alzheimer’s in patients early on, and in a non-invasive and accurate way. Through geometric modelling and cloud-based AI modelling, we can determine how the brain is likely to develop and work five years into the future,” says Kamali-Zare.
Early detection of Alzheimer’s thanks to groundbreaking medical technology
Video interview with Padideh Kamali-Zare (3.31)
Award committee citation 2023
"The 2023 recipient of the KTH Innovation Award addresses one of the biggest healthcare challenges of our time: dementia. Living through the progression of her grandmother’s Alzheimer’s disease ignited a spark that took her through studies and research in Biological Physics at KTH on to founding and building a company developing breakthrough solutions for the early detection of neurodegenerative disease. Her work is becoming an important puzzle piece in the fight against dementia. The 2023 KTH Innovation Award goes to Padideh Kamali-Zare, founder of Darmiyan."
The 2023 members of the award committee were KTH President Anders Söderholm, investor Klaus Hommels, business angel Jane Walerud, KTH professor Stefan Ståhl, and the 2022 recipient of the Award Janne Wallenius.